Combating Alzheimer Disease by multitarget pyridinylidene hydrazones

It was surprisingly found that the pyridinylidene hydrazone derivatives inhibit AChE and BuChE as well as Aβ fibril formation significantly. They can destroy already formed fibrils. And they are able to cross the blood-brain barrier which is thought to be due to their pKa values and lipophilicity.

Further Information: PDF

Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0

Contact
Peer Biskup

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Silicone sponge captures unknown bacteria

KIT researchers develop a chip that captures microbial dark matter in air, water, and soil – new tool for biotechnology and medicine. From human intestines to the bottom of the…

An exoplanet atmosphere as never seen before

The JWST just scored another first: a detailed molecular and chemical portrait of a distant world’s skies. The telescope’s array of highly sensitive instruments was trained on the atmosphere of…

AI tailors artificial DNA for future drug development

With the help of an AI, researchers at Chalmers University of Technology, Sweden, have succeeded in designing synthetic DNA that controls the cells’ protein production.  The technology can contribute to…

Partners & Sponsors